---
id: 092
title: Tuberculosis Treatment Regimens
category: clinical_syndromes
subcategory: tuberculosis
tags: [TB, RIPE, rifampin, isoniazid, pyrazinamide, ethambutol, latent-TB]
difficulty: medium
---

## Question

How is tuberculosis treated? Use the **"RIPE for 2 months → RI for 4 months"** framework for drug-susceptible TB.

## Answer

### **"RIPE" Mnemonic for Active TB:**

**R** = **Rifampin** 600mg daily (10 mg/kg)
**I** = **Isoniazid** 300mg daily (5 mg/kg) + **pyridoxine (B6)** 25-50mg daily
**P** = **Pyrazinamide** 1000-2000mg daily (weight-based)
**E** = **Ethambutol** 800-1600mg daily (15-25 mg/kg)

### **Treatment Duration:**

**Drug-Susceptible Pulmonary TB:**
- **Intensive phase:** **RIPE × 2 months** (all 4 drugs)
- **Continuation phase:** **RI × 4 months** (rifampin + isoniazid)
- **Total: 6 months**

**Exceptions (longer duration):**
- **Cavitary disease + positive 2-month culture:** Extend continuation to 7 months (total 9 months)
- **CNS TB (meningitis):** 9-12 months + corticosteroids
- **Bone/joint TB:** 6-9 months
- **Drug-resistant TB:** 18-24 months (specialist consultation)

### **Latent TB Infection (LTBI) Regimens:**

| Regimen | Duration | Notes |
|---------|----------|-------|
| **Rifampin** (R) | **4 months** | **Preferred** (better adherence) |
| **Isoniazid** (H) | **9 months** | Traditional, requires B6 |
| **Rifapentine + Isoniazid** (3HP) | **12 weekly doses** | Directly observed, best adherence |
| **Rifampin + Isoniazid** (3RH) | **3 months** | Alternative |

## Key Points

### **Why Each Drug:**
- **Rifampin:** Most potent sterilizing drug (kills dormant bacilli)
- **Isoniazid:** Kills rapidly dividing bacilli
- **Pyrazinamide:** Active in acidic environment (macrophages)
- **Ethambutol:** Prevents resistance (can stop if susceptible)

### **Monitoring:**
- **Baseline:** LFTs, CBC, creatinine, visual acuity (ethambutol), HIV test
- **Monthly:** Symptoms, adherence, LFTs if abnormal baseline
- **2 months:** Sputum culture (should be negative)

### **Drug Interactions:**
- **Rifampin:** Strong CYP3A4 inducer (decreases levels of many drugs: antiretrovirals, warfarin, oral contraceptives)
- Consider **rifabutin** if significant drug interactions

### **Side Effects:**
- **Rifampin:** Orange urine, hepatotoxicity, drug interactions
- **Isoniazid:** Hepatotoxicity, peripheral neuropathy (give B6)
- **Pyrazinamide:** Hepatotoxicity, hyperuricemia/gout
- **Ethambutol:** Optic neuritis (dose-dependent, check visual acuity monthly)

### **Clinical Pearls:**
- **RIPE × 2 months → RI × 4 months** (6 months total)
- **Always give pyridoxine (B6)** with isoniazid (prevent neuropathy)
- **Rifampin** preferred over isoniazid for LTBI (4 months vs 9 months)
- **DOT (directly observed therapy)** improves adherence
- **Rifampin** causes orange urine (warn patients)

## Sources

- [CDC: Treatment Regimens for TB 2024]
- [ATS/CDC/IDSA: Treatment of Drug-Susceptible TB 2023]

## Media

N/A
